Drug Trial Radar · NCT06729021
Predictive Value of Modified Caprini Score and D-Dimer in Managing Lower Limb Venous Thrombosis in Cardiothoracic Patients
Last checked: Nov 20, 2026Latest source record: Sep 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
112
Planned (sponsor's estimate)
Start
Jan 20, 2025
Primary completion
Jul 20, 2027
Study completion Jul 30, 2027
Sponsor
- Lead sponsor
- Al-Nahrain UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 11, 2024
Design
- Study type
- Observational
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this observational study is to evaluate the predictive efficacy of the Modified Caprini Risk Assessment Score and D-Dimer in identifying and managing lower extremity venous thrombosis (LEVT) among cardiothoracic surgery patients in Baghdad. The main questions it aims to answer are: Does combining the Modified Caprini Score with D-Dimer improve the accuracy of predicting lower extremity venous thrombosis (LEVT) compared to using each tool independently? Can these tools effectively guide clinical decisions for lower extremity venous thrombosis (LEVT) prevention and management in this patient population? Participants will: Undergo risk assessment for lower extremity venous thrombosis (LEVT) using the Modified Caprini Score and have their D-Dimer levels measured during their hospital stay. Be monitored for clinical outcomes, including confirmed lower extremity venous thrombosis (LEVT) incidence, need for anticoagulation therapy, and complications such as pulmonary embolism or recurrent thrombosis.
Conditions
- DVT - Deep Vein Thrombosis
Interventions
GCSDevice
Graduated compression stockings may be used after procedure by the decision of the doctor
LMWHDrug
Low-molecular-weight heparin may be used after procedure by the decision of the doctor
Primary outcomes
What the sponsor says the trial is designed to measure.
- any episode of VTE (Venous Thromboembolism)Time frame: In-Hospital Phase (average of 7 days through discharge); Post-Discharge Follow-Up: Day 7, Day 15, and Day 30
- Caprini risk assessment model scoresTime frame: Day 1 preoperative (one day prior to surgery)
- Concentration of D-dimer in Blood SamplesTime frame: Day 1 postoperative (the first day after surgery)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
College of Medicine - Al-Nahrain University
Baghdad, Iraq · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.